MARIE BASA: Open Payments
NPI 1356739767 · FOUNTAIN VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 39 payments from 12 companies in 2025. Trend: 2023 $986 · 2024 $957 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $228 |
| Novo Nordisk Inc | 10 | $169 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $94 |
| Lilly USA, LLC | 4 | $80 |
| Amgen Inc. | 2 | $53 |
| Getinge USA Sales, LLC | 2 | $38 |
| ABBVIE INC. | 1 | $33 |
| PFIZER INC. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
Products named: AIRSUPRA, JARDIANCE, Ozempic, BREZTRI, MOUNJARO, OTEZLA, VASOVIEW HEMOPRO 2, VRAYLAR.
Industry payments across CA — which companies pay providers there.
